← Back to Search

Gamma Wave Therapy for Traumatic Brain Injury (DAGABBI Trial)

N/A
Recruiting
Led By Kevin M. Spencer, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18-65 years
Be older than 18 years old
Must not have
Cognitive disorder due to general medical condition other than TBI
Self-reported severe depression or anxiety requiring hospitalization overnight, or current active homicidal and/or suicidal ideation with intent requiring crisis intervention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether using gamma waves can help improve symptoms for veterans who have experienced blast-related brain injuries.

Who is the study for?
This trial is for post-9/11 combat veterans aged 18-65 who have experienced blast exposure and are part of the VA Boston Healthcare System. It includes those exposed to blasts from less than or more than 10 meters away, with groups matched by age and gender. Veterans must not have severe mental health issues, neurological illnesses, substance abuse problems, or hearing impairments.
What is being tested?
The study tests auditory gamma sensory stimulation as a potential treatment for cognitive and emotional problems caused by blast-related brain injuries in veterans. The focus is on detecting and improving abnormalities in brain wave patterns known as gamma oscillations.
What are the potential side effects?
Since this trial involves non-invasive auditory stimulation rather than medication, traditional side effects like you might see with drugs are not expected. However, participants may experience discomfort or other sensations related to the auditory stimulus.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a cognitive disorder not caused by traumatic brain injury.
Select...
I have severe depression or anxiety that required hospitalization or have had serious thoughts of harming myself or others.
Select...
I have a history of neurological illnesses like Huntington's or Parkinson's.
Select...
I have had seizures not caused by a head injury.
Select...
I have been diagnosed with schizophrenia, bipolar, or another psychotic disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in evoked gamma power of conditioned vs. unconditioned tones
Change in spontaneous gamma power

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
All participants receive auditory gamma sensory stimulation.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,759 Total Patients Enrolled
Kevin M. Spencer, PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Media Library

Auditory gamma sensory stimulation Clinical Trial Eligibility Overview. Trial Name: NCT03836976 — N/A
Concussion Research Study Groups: All participants
Concussion Clinical Trial 2023: Auditory gamma sensory stimulation Highlights & Side Effects. Trial Name: NCT03836976 — N/A
Auditory gamma sensory stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03836976 — N/A
~5 spots leftby Jul 2025